Wu learned that Windtree Therapeutics (WINT), a biotechnology company listed on NASDAQ, announced that it has signed up to $500 million in Common Stock Purchase Agreements (ELOC) and an additional $20 million in stock purchase agreements, with a total financing scale of up to $520 million, of which 99% will be used to purchase BNB. The company plans to officially initiate the use of funds after obtaining shareholder approval to increase the authorized number of common shares. https://www. (wublock123.com)/index.php? m=content&c=index&a=show&catid=6&id=46174